Advertisement

Reactions Weekly

, Volume 1779, Issue 1, pp 3–3 | Cite as

PRAC completes reviews of alemtuzumab and tofacitinib

Unknown
  • 92 Downloads

Reference

  1. Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 28-31 October 2019. Internet Document : 13 Nov 2019. Available from: URL: https://www.ema.europa.eu/en/news/meeting-highlights-pharmacovigilance-risk-assessment-committee-prac-28-31-october-2019

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations